These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 7705451
1. Selective in vivo labelling of brain 5-HT1A receptors by [3H]WAY 100635 in the mouse. Laporte AM, Lima L, Gozlan H, Hamon M. Eur J Pharmacol; 1994 Dec 27; 271(2-3):505-14. PubMed ID: 7705451 [Abstract] [Full Text] [Related]
2. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes. Gozlan H, Thibault S, Laporte AM, Lima L, Hamon M. Eur J Pharmacol; 1995 Jan 16; 288(2):173-86. PubMed ID: 7720779 [Abstract] [Full Text] [Related]
3. Evaluation of [O-methyl-3H]WAY-100635 as an in vivo radioligand for 5-HT1A receptors in rat brain. Hume SP, Ashworth S, Opacka-Juffry J, Ahier RG, Lammertsma AA, Pike VW, Cliffe IA, Fletcher A, White AC. Eur J Pharmacol; 1994 Dec 27; 271(2-3):515-23. PubMed ID: 7705452 [Abstract] [Full Text] [Related]
4. Atypical in vitro and in vivo binding of [3H]S-14506 to brain 5-HT1A receptors. Lima L, Laporte AM, Gaymard C, Spedding M, Mocaër E, Hamon M. J Neural Transm (Vienna); 1997 Dec 27; 104(10):1059-75. PubMed ID: 9503258 [Abstract] [Full Text] [Related]
5. [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia. Burnet PW, Eastwood SL, Harrison PJ. Neurochem Int; 1997 Jun 27; 30(6):565-74. PubMed ID: 9152998 [Abstract] [Full Text] [Related]
6. Quantitative autoradiographic characterisation of the binding of [3H]WAY-100635, a selective 5-HT1A receptor antagonist. Khawaja X. Brain Res; 1995 Mar 06; 673(2):217-25. PubMed ID: 7606435 [Abstract] [Full Text] [Related]
7. In vivo labelling of the mouse brain 5-hydroxytryptamine1A receptor with the novel selective antagonist 3H-NAD-299. Stenfors C, Werner T, Ross SB. Naunyn Schmiedebergs Arch Pharmacol; 1998 May 06; 357(5):500-7. PubMed ID: 9650801 [Abstract] [Full Text] [Related]
8. Interactions of lesopitron (E-4424) with central 5-HT1A receptors: in vitro and in vivo studies in the rat. Haj-Dahmane S, Jolas T, Laporte AM, Gozlan H, Farré AJ, Hamon M, Lanfumey L. Eur J Pharmacol; 1994 Apr 01; 255(1-3):185-96. PubMed ID: 8026543 [Abstract] [Full Text] [Related]
9. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635. Hall H, Lundkvist C, Halldin C, Farde L, Pike VW, McCarron JA, Fletcher A, Cliffe IA, Barf T, Wikström H, Sedvall G. Brain Res; 1997 Jan 16; 745(1-2):96-108. PubMed ID: 9037397 [Abstract] [Full Text] [Related]
12. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635. Khawaja X, Ennis C, Minchin MC. Life Sci; 1997 Jan 16; 60(9):653-65. PubMed ID: 9048968 [Abstract] [Full Text] [Related]
13. Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain. Corradetti R, Laaris N, Hanoun N, Laporte AM, Le Poul E, Hamon M, Lanfumey L. Br J Pharmacol; 1998 Feb 16; 123(3):449-62. PubMed ID: 9504386 [Abstract] [Full Text] [Related]
19. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo. Pike VW, Halldin C, McCarron JA, Lundkvist C, Hirani E, Olsson H, Hume SP, Karlsson P, Osman S, Swahn CG, Hall H, Wikström H, Mensonidas M, Poole KG, Farde L. Eur J Nucl Med; 1998 Apr 25; 25(4):338-46. PubMed ID: 9553162 [Abstract] [Full Text] [Related]
20. Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100 135 and SDZ 216-525. Lanfumey L, Haj-Dahmane S, Hamon M. Eur J Pharmacol; 1993 Nov 02; 249(1):25-35. PubMed ID: 8282017 [Abstract] [Full Text] [Related] Page: [Next] [New Search]